Heterogeneity‐based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case report.

MLA

Liu, Yutao, et al. “Heterogeneity‐based, Multiple Mechanisms in the Resistance to Osimertinib (AZD9291): A Case Report.” Thoracic Cancer, vol. 9, no. 4, Apr. 2018, pp. 498–501. EBSCOhost, https://doi.org/10.1111/1759-7714.12596.

APA

Liu, Y., Hao, X., Hu, X., Li, J., Wang, Y., Wang, H., Xing, P., Li, W., Ying, J., Han, X., & Shi, Y. (2018). Heterogeneity‐based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case report. Thoracic Cancer, 9(4), 498–501. https://doi.org/10.1111/1759-7714.12596

Chicago

Liu, Yutao, Xuezhi Hao, Xingsheng Hu, Junling Li, Yan Wang, Hongyu Wang, Puyuan Xing, et al. 2018. “Heterogeneity‐based, Multiple Mechanisms in the Resistance to Osimertinib (AZD9291): A Case Report.” Thoracic Cancer 9 (4): 498–501. doi:10.1111/1759-7714.12596.